Transgenic expression of Korean type hepatitis C virus core protein and related mutants in mice

被引:5
作者
Wang, AG
Moon, HB
Lee, YH
Yu, SL
Kwon, HJ
Han, YH
Fang, W
Lee, TH
Jang, KL
Kim, SK
Yu, DY
Lee, DS [1 ]
机构
[1] KRIBB, Lab Human Genomics, Taejon 305806, South Korea
[2] Wonkwang Univ, Sch Med, Dept Pathol, Iksan 570749, South Korea
[3] Wonkwang Univ, Sch Med, Inst Med Sci, Iksan 570749, South Korea
[4] Chungnam Natl Univ, Coll Med, Dept Anat, Taejon 301131, South Korea
[5] Chonnam Natl Univ, Coll Dent, Dept Oral Biochem, Kwangju 500757, South Korea
[6] Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, Pusan 609735, South Korea
[7] Chungnam Natl Univ, Coll Vet Med, Taejon 305764, South Korea
关键词
core; dysplasia; hepatitis C virus; transgenic mice;
D O I
10.1038/emm.2004.76
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis C virus (HCV) is a major causative agent in liver disease. In order to investigate if Korean type HCV core protein and its related mutants, S99Q and S116I, are cytopathic to liver, three types of transgenic mice were established. The expression of transgenes was confirmed by HCV specific RT-PCR and Western immunoblotting. The livers of all wild type core and S116I transgenic lineages remained largely histologically normal. However, the livers of the S99Q transgenic mice showed significant high level of cell dysplasia associated with the transgene expression in hepatocytes largely located around the central veins by in situ hybridization analysis. In conclusion, the mutant HCV core protein at S99Q may contribute to the progress of HCV induced liver disease.
引用
收藏
页码:588 / 593
页数:6
相关论文
共 25 条
[1]  
CHISARI FV, 1995, HEPATOLOGY, V22, P1316, DOI 10.1016/0270-9139(95)90645-2
[2]   Partial rescue of the Na+-Ca2+ exchanger (NCX1) knock-out mouse by transgenic expression of NCX1 [J].
Cho, CH ;
Lee, SY ;
Shin, HS ;
Philipson, KD ;
Lee, CO .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2003, 35 (02) :125-135
[3]   VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression [J].
Han, SH ;
Jeon, JH ;
Ju, HR ;
Jung, U ;
Kim, KY ;
Sook, H ;
Yoo, HS ;
Lee, YH ;
Song, KS ;
Hwang, HM ;
Na, YS ;
Yang, Y ;
Lee, KN ;
Choi, I .
ONCOGENE, 2003, 22 (26) :4035-4046
[4]  
HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403
[5]  
JANG KL, 1993, MOL CELLS, V3, P419
[6]   The repressive activity of hepatitis C virus core protein on the transcription of p21waf1 is regulated by protein kinase A-mediated phosphorylation [J].
Jung, EY ;
Lee, MN ;
Yang, HY ;
Yu, DY ;
Jang, KL .
VIRUS RESEARCH, 2001, 79 (1-2) :109-115
[7]  
KAMAL G, 2001, ATLAS TUMOR PATHOL T
[8]   Transgenic expression of hepatitis C virus structural proteins in the mouse [J].
Kawamura, T ;
Furusaka, A ;
Koziel, MJ ;
Chung, RT ;
Wang, TC ;
Schmidt, EV ;
Liang, TJ .
HEPATOLOGY, 1997, 25 (04) :1014-1021
[9]   AN ASSAY FOR CIRCULATING ANTIBODIES TO A MAJOR ETIOLOGIC VIRUS OF HUMAN NON-A, NON-B-HEPATITIS [J].
KUO, G ;
CHOO, QL ;
ALTER, HJ ;
GITNICK, GL ;
REDEKER, AG ;
PURCELL, RH ;
MIYAMURA, T ;
DIENSTAG, JL ;
ALTER, MJ ;
STEVENS, CE ;
TEGTMEIER, GE ;
BONINO, F ;
COLOMBO, M ;
LEE, WS ;
KUO, C ;
BERGER, K ;
SHUSTER, JR ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :362-364
[10]   Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea [J].
Kwon, SY ;
Ahn, MS ;
Chang, HJ .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (11) :1282-1286